Details
Stereochemistry | ACHIRAL |
Molecular Formula | C30H29N3O |
Molecular Weight | 447.5708 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCC1=CC=C(CN2N=C(C(=O)NC3=C4C=CC=CC4=CC=C3)C5=C2C=CC=C5)C=C1
InChI
InChIKey=BLOQUZQMKJZVQE-UHFFFAOYSA-N
InChI=1S/C30H29N3O/c1-2-3-4-10-22-17-19-23(20-18-22)21-33-28-16-8-7-14-26(28)29(32-33)30(34)31-27-15-9-12-24-11-5-6-13-25(24)27/h5-9,11-20H,2-4,10,21H2,1H3,(H,31,34)
Molecular Formula | C30H29N3O |
Molecular Weight | 447.5708 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL253 Sources: https://www.ncbi.nlm.nih.gov/pubmed/29549157 |
1.233 nM [EC50] | ||
Target ID: CHEMBL218 Sources: https://www.ncbi.nlm.nih.gov/pubmed/29549157 |
2.028 nM [EC50] |
Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 17:08:09 GMT 2025
by
admin
on
Tue Apr 01 17:08:09 GMT 2025
|
Record UNII |
GP2N1PG5X2
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-MN-18
Created by
admin on Tue Apr 01 17:08:09 GMT 2025 , Edited by admin on Tue Apr 01 17:08:09 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1391484-80-2
Created by
admin on Tue Apr 01 17:08:09 GMT 2025 , Edited by admin on Tue Apr 01 17:08:09 GMT 2025
|
PRIMARY | |||
|
GP2N1PG5X2
Created by
admin on Tue Apr 01 17:08:09 GMT 2025 , Edited by admin on Tue Apr 01 17:08:09 GMT 2025
|
PRIMARY | |||
|
MN-18
Created by
admin on Tue Apr 01 17:08:09 GMT 2025 , Edited by admin on Tue Apr 01 17:08:09 GMT 2025
|
PRIMARY | MN 18 is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug. It is the indazole core analogue of NNE1. Given the known metabolic liberation (and presence as an impurity) of amantadine in the related compound APINACA, it is suspected that metabolic hydrolysis of the amide group of MN-18 may release 1-naphthylamine, a known carcinogen. MN-18 is banned in Sweden. | ||
|
MN-18
Created by
admin on Tue Apr 01 17:08:09 GMT 2025 , Edited by admin on Tue Apr 01 17:08:09 GMT 2025
|
PRIMARY | MN-18 is a synthetic cannabinoid modeled after AKB48 (APINACA, Item No. 11566), with the adamantyl group replaced by a naphthalenyl group. The physiological and toxicological properties of this compound are unknown. This product is intended for forensic and research applications. | ||
|
DTXSID301010033
Created by
admin on Tue Apr 01 17:08:09 GMT 2025 , Edited by admin on Tue Apr 01 17:08:09 GMT 2025
|
PRIMARY | |||
|
154925762
Created by
admin on Tue Apr 01 17:08:09 GMT 2025 , Edited by admin on Tue Apr 01 17:08:09 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
Ki
|
||
|
TARGET -> AGONIST |
Ki
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |